“Right now, pricing is not on the docket for us to take again.”

In context

“Chen with Cowen and Company. Please go ahead. Tom Nass: Hi, thanks for taking my call. It's Tom on for Oliver. A question on pricing. How should we think about the potential for price increases going forward this year and the demand elasticity in that regard? And additionally, have you seen any slowdown in demand and so where might those pressure points be? Mandy Fields: Yes. So I'll take the question on pricing. We have used pricing very judiciously over the last several years. We really have only taken two major price increases: one back in 2019 related to tariffs, where we touch about a third of our portfolio from a pricing standpoint and then last March in response to the inflationary environment that we're all operating in where we took pricing on about two-thirds of our portfolio. Right now, pricing is not on the docket for us to take again. We take very seriously our ability to provide our consumers with an extraordinary value with exceptional quality and we'll continue to do that. So, right now, pricing not on the docket for us. And, go ahead. On your second question, I’ll pass it to Tarang. Tarang Amin: On the slowdown, yes. No, we've not seen any slowdown in demand. I know there's a lot of concerns out there on recessionary environment. What I'd tell you is, historically, mass color cosmetics, mass skin care has fared really well in inflationary environments, but – or recessionary environments, but even more importantly, we've long been bullish on the category. And this is a category that really did suffer during the pandemic when people were restricted from their normal behavior. So I've long felt there's a lot of pent-”